Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04528316
Other study ID # CCHE-BT003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 6, 2020
Est. completion date April 30, 2021

Study information

Verified date August 2021
Source Children's Cancer Hospital Egypt 57357
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. It has been reported that those children fall frequently so the purpose of this study is to investigate the effectiveness of balance and coordination training in these Children.


Description:

The effects of physical exercise training interventions for childhood cancer participants are not yet convincing due to small numbers of participants and insufficient study methodology. More and high-quality evidence is needed in order to be able to draft exercise and physical activity guidelines for this population. Despite the positive results of exercise interventions in adult cancer patients, the evidence for benefits in childhood cancer patients is limited. There are Two Main objectives: 1. To investigate the effectiveness of Pilates core stability exercises program. 2. To investigate the effectiveness of Humac balance and tilt system. Secondary Objectives: 1. The effectiveness of coordination training in children with posterior fossa tumors. 2. The comparison between balance and coordination training and which of both trainings has more effect. This study will take place in a pediatric oncology setting, Children's Cancer Hospital Egypt(CCHE), in outpatient setting. Patients will be evaluated for their balance and coordination at initial presentation, during treatment, and during follow-up after end of treatment at CCHE. Also patients will receive balance and coordination training, before each chemotherapy cycle-maximum one week- given the patient is in good state. Sixty children with posterior fossa tumors of both sexes will participate in this study. They will be selected from CCHE. They will be randomly assigned into 3 groups of equal number.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers No
Gender All
Age group 5 Years to 12 Years
Eligibility Inclusion Criteria: 1. Children with posterior fossa tumors during follow up. 2. Children between 5-12 years old. 3. Time elapsed since the start of treatment more than 4 months in order to be in maintenance phase. 4. They can understand verbal command. 5. Children with no visual, auditory or perceptual disorders. 6. Children are already treated surgically. Exclusion Criteria: - Children who have one or more of the following criteria will be excluded from the study: 1. Children with a genetic disorder or mental retardation. 2. Children with a chronic lung disease. 3. Sever cardiomyopathy (ejection fraction <40%, ischemia and angina pectoris at rest). 4. Children with a neuromuscular disease not related to tumor.

Study Design


Intervention

Behavioral:
Pilates Core Stability Exercises program
Twenty patients will receive Pilates core stability exercises program ONLY. Total Period: 12 Weeks Stages: Three stages: Stage I: Warm-up: consists of four Pilates motions: Breathing: Rolling back: Coccyx-curl: Hundred breathing: Stage II: Work-out: consists of twelve Pilates motions: Single leg stretch: Straight leg raise: Basic bridge: Bridging variation: Quadruped: Clap with seal motion Mermaid twist: Swimming: Double leg stretch: Shoulder bridge: Swan dive: Leg full front: Stage III: Cool-down: consists of three Pilates motions: Rest position: Cat with arm/leg extension: Breathing:
Balance Program
Total Period: 12 Weeks. The designed HUMAC program will work on the modified clinical test of sensory integration of balance (mCTSIB) with eyes open and with eyes closed, the center of pressure (COP) and the limit of stability test (LOS).
Coordination
Total Period: 12 Weeks. Coordination will be assessed using BOT2, Bilateral coordination (Sub test No.4) composed of 7 items and Upper-Limb coordination (Sub test No.7) composed of 7 items too. The raw scores are recorded first then it is converted into point scores, then subtest total point score is obtained by adding point scores.

Locations

Country Name City State
Egypt Children's Cancer Hospital Egypt 57357 Cairo

Sponsors (1)

Lead Sponsor Collaborator
Children's Cancer Hospital Egypt 57357

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change Balance For assessment of the three groups, HUMAC balance and tilt system will be used to assess both Static and dynamic balance. at week 12
Secondary Change Coordination The Bruininks-Oseretsky Test of Motor Proficiency - Second Edition
- The minimum and maximum values: Coordination will be assessed using BOT2, Bilateral coordination (Sub test No.4) composed of 7 items and Upper-Limb coordination (Sub test No.7) composed of 7 items too.
The raw scores are recorded first then it is converted into point scores, then subtest total point score is obtained by adding point scores.
Bilateral Coordination: Total Point Score Subtest (min=Zero, max=24). Upper-Limb Coordination: Total Point Score Subtest (min=Zero, max=39).
- Higher scores mean a better outcome.
at week 12
See also
  Status Clinical Trial Phase
Terminated NCT04167618 - 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma Phase 1/Phase 2
Active, not recruiting NCT03288168 - Children's and Adolescents' Medulloblastoma Molecular Subgroups in China
Recruiting NCT05298995 - GD2-CAR T Cells for Pediatric Brain Tumours Phase 1
Recruiting NCT04174820 - Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Completed NCT04860934 - Dual Task Training On Children With Ataxia After Medulloblastoma Resection N/A
Active, not recruiting NCT06193759 - Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) Phase 1
Suspended NCT03904862 - Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Phase 1/Phase 2
Withdrawn NCT01697514 - A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma Phase 1
Recruiting NCT05230758 - Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour Phase 3
Not yet recruiting NCT05406947 - Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
Completed NCT02238899 - Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma N/A
Recruiting NCT05057702 - Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma N/A
Recruiting NCT04185038 - Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors Phase 1
Terminated NCT02624388 - Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Phase 2